{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:20:28Z","timestamp":1791267628207,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2004,7,29]],"date-time":"2004-07-29T00:00:00Z","timestamp":1091059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,7,29]],"date-time":"2004-07-29T00:00:00Z","timestamp":1091059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2004,10,1]]},"DOI":"10.1038\/sj.leu.2403443","type":"journal-article","created":{"date-parts":[[2004,7,30]],"date-time":"2004-07-30T05:37:22Z","timestamp":1091165842000},"page":"1711-1716","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas"],"prefix":"10.1038","volume":"18","author":[{"given":"C","family":"Kelaidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Rollot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tulliez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Christoforov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Calmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Podevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Bouscary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Sogni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Blanche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Dreyfus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,7,29]]},"reference":[{"key":"BF2403443_CR1","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/j.1365-2141.1994.tb05036.x","volume":"88","author":"C Ferri","year":"1994","unstructured":"Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994; 88: 392\u2013394.","journal-title":"Br J Haematol"},{"key":"BF2403443_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1046\/j.1365-2141.1996.d01-1791.x","volume":"94","author":"M Luppi","year":"1996","unstructured":"Luppi M, Longo G, Ferrari MG, Ferrara L, Marasca R, Barozzi P et al. Additional neoplasms and HCV infection in low-grade lymphoma of MALT type. Br J Haematol 1996; 94: 373\u2013375.","journal-title":"Br J Haematol"},{"key":"BF2403443_CR3","first-page":"351","volume":"10","author":"M Luppi","year":"1996","unstructured":"Luppi M, Grazia Ferrari M, Bonaccorsi G, Longo G, Narni F, Barozzi P et al. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia. Leukemia 1996; 10: 351\u2013355.","journal-title":"Leukemia"},{"key":"BF2403443_CR4","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1046\/j.1365-2141.1996.6912313.x","volume":"94","author":"C Mazzaro","year":"1996","unstructured":"Mazzaro C, Zagonel V, Monfardini S, Tulissi P, Pussini E, Fanni M et al. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 1996; 94: 544\u2013550.","journal-title":"Br J Haematol"},{"key":"BF2403443_CR5","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1182\/blood.V87.10.4296.bloodjournal87104296","volume":"87","author":"F Silvestri","year":"1996","unstructured":"Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996; 87: 4296\u20134301.","journal-title":"Blood"},{"key":"BF2403443_CR6","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s007050050100","volume":"142","author":"AL Zignego","year":"1997","unstructured":"Zignego AL, Ferri C, Giannini C, La Civita L, Careccia G, Longombardo G et al. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role. Arch Virol 1997; 142: 545\u2013555.","journal-title":"Arch Virol"},{"key":"BF2403443_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1046\/j.1365-2257.1998.00110.x","volume":"20","author":"PD King","year":"1998","unstructured":"King PD, Wilkes JD, Diaz-Arias AA . Hepatitis C virus infection in non-Hodgkin's lymphoma. Clin Lab Haematol 1998; 20: 107\u2013110.","journal-title":"Clin Lab Haematol"},{"key":"BF2403443_CR8","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/hep.510290422","volume":"29","author":"JD Collier","year":"1999","unstructured":"Collier JD, Zanke B, Moore M, Kessler G, Krajden M, Shepherd F et al. No association between hepatitis C and B-cell lymphoma. Hepatology 1999; 29: 1259\u20131261.","journal-title":"Hepatology"},{"key":"BF2403443_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3109\/10428199709109167","volume":"26","author":"MD McColl","year":"1997","unstructured":"McColl MD, Singer IO, Tait RC, McNeil IR, Cumming RL, Hogg RB . The role of hepatitis C virus in the aetiology of non-Hodgkins lymphoma \u2013 a regional association? Leuk Lymphoma 1997; 26: 127\u2013130.","journal-title":"Leuk Lymphoma"},{"key":"BF2403443_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0168-8278(98)80199-2","volume":"28","author":"V Ellenrieder","year":"1998","unstructured":"Ellenrieder V, Weidenbach H, Frickhofen N, Michel D, Prummer O, Klatt S et al. HCV and HGV in B-cell non-Hodgkin's lymphoma. J Hepatol 1998; 28: 34\u201339.","journal-title":"J Hepatol"},{"key":"BF2403443_CR11","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1182\/blood.V93.5.1778","volume":"93","author":"G Germanidis","year":"1999","unstructured":"Germanidis G, Haioun C, Pourquier J, Gaulard P, Pawlotsky JM, Dhumeaux D et al. Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center. Blood 1999; 93: 1778\u20131779.","journal-title":"Blood"},{"key":"BF2403443_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ajh.1101","volume":"67","author":"P Hausfater","year":"2001","unstructured":"Hausfater P, Cacoub P, Sterkers Y, Thibault V, Amoura Z, Nguyen L et al. Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1576 patients in France. Am J Hematol 2001; 67: 168\u2013171.","journal-title":"Am J Hematol"},{"key":"BF2403443_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.7326\/0003-4819-127-6-199709150-00002","volume":"127","author":"E Zuckerman","year":"1997","unstructured":"Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997; 127: 423\u2013428.","journal-title":"Ann Intern Med"},{"issue":"Suppl. 3","key":"BF2403443_CR14","first-page":"516","volume":"11","author":"T Izumi","year":"1997","unstructured":"Izumi T, Sasaki R, Tsunoda S, Akutsu M, Okamoto H, Miura Y . B cell malignancy and hepatitis C virus infection. Leukemia 1997; 11 (Suppl. 3): 516\u2013518.","journal-title":"Leukemia"},{"key":"BF2403443_CR15","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1182\/blood-2002-01-0226","volume":"99","author":"CS Rabkin","year":"2002","unstructured":"Rabkin CS, Tess BH, Christianson RE, Wright WE, Waters DJ, Alter HJ et al. Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia. Blood 2002; 99: 4240\u20134242.","journal-title":"Blood"},{"key":"BF2403443_CR16","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1002\/hep.1840360621","volume":"36","author":"HB El-Serag","year":"2002","unstructured":"El-Serag HB, Hampel H, Yeh C, Rabeneck L . Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 2002; 36: 1439\u20131445.","journal-title":"Hepatology"},{"key":"BF2403443_CR17","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1182\/blood-2002-10-3230","volume":"102","author":"A Mele","year":"2003","unstructured":"Mele A, Pulsoni A, Bianco E, Musto P, Szklo A, Sanpaolo MG et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case\u2013control study. Blood 2003; 102: 996\u2013999.","journal-title":"Blood"},{"key":"BF2403443_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/cncr.11893","volume":"100","author":"L Arcaini","year":"2004","unstructured":"Arcaini L, Paulli M, Boveri E, Vallisa D, Bernuzzi P, Orlandi E et al. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles. Cancer 2004; 100: 107\u2013115.","journal-title":"Cancer"},{"key":"BF2403443_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1046\/j.1365-2141.2001.02573.x","volume":"112","author":"E Zuckerman","year":"2001","unstructured":"Zuckerman E, Zuckerman T, Sahar D, Streichman S, Attias D, Sabo E et al. bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection. Br J Haematol 2001; 112: 364\u2013369.","journal-title":"Br J Haematol"},{"key":"BF2403443_CR20","doi-asserted-by":"publisher","first-page":"571","DOI":"10.7326\/0003-4819-137-7-200210010-00008","volume":"137","author":"AL Zignego","year":"2002","unstructured":"Zignego AL, Ferri C, Giannelli F, Giannini C, Caini P, Monti M et al. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med 2002; 137: 571\u2013580.","journal-title":"Ann Intern Med"},{"key":"BF2403443_CR21","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.4049\/jimmunol.160.7.3594","volume":"160","author":"D Sansonno","year":"1998","unstructured":"Sansonno D, De Vita S, Iacobelli AR, Cornacchiulo V, Boiocchi M, Dammacco F . Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol 1998; 160: 3594\u20133601.","journal-title":"J Immunol"},{"key":"BF2403443_CR22","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1182\/blood.V97.4.1023","volume":"97","author":"CH Chan","year":"2001","unstructured":"Chan CH, Hadlock KG, Foung SK, Levy S . V(H)1\u201369 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen. Blood 2001; 97: 1023\u20131026.","journal-title":"Blood"},{"key":"BF2403443_CR23","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1182\/blood.V96.10.3578","volume":"96","author":"V De Re","year":"2000","unstructured":"De Re V, De Vita S, Marzotto A, Rupolo M, Gloghini A, Pivetta B et al. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 2000; 96: 3578\u20133584.","journal-title":"Blood"},{"key":"BF2403443_CR24","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1182\/blood.V91.7.2433","volume":"91","author":"M Ivanovski","year":"1998","unstructured":"Ivanovski M, Silvestri F, Pozzato G, Anand S, Mazzaro C, Burrone OR et al. Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1\/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 1998; 91: 2433\u20132442.","journal-title":"Blood"},{"key":"BF2403443_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0002-9440(10)61691-4","volume":"159","author":"R Marasca","year":"2001","unstructured":"Marasca R, Vaccari P, Luppi M, Zucchini P, Castelli I, Barozzi P et al. Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma. Am J Pathol 2001; 159: 253\u2013261.","journal-title":"Am J Pathol"},{"key":"BF2403443_CR26","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1182\/blood.V98.13.3745","volume":"98","author":"ER Quinn","year":"2001","unstructured":"Quinn ER, Chan CH, Hadlock KG, Foung SK, Flint M, Levy S . The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 2001; 98: 3745\u20133749.","journal-title":"Blood"},{"key":"BF2403443_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/1097-0215(20000715)87:2<211::AID-IJC9>3.0.CO;2-8","volume":"87","author":"V De Re","year":"2000","unstructured":"De Re V, De Vita S, Marzotto A, Gloghini A, Pivetta B, Gasparotto D et al. Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process. Int J Cancer 2000; 87: 211\u2013216.","journal-title":"Int J Cancer"},{"key":"BF2403443_CR28","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1126\/science.282.5390.938","volume":"282","author":"P Pileri","year":"1998","unstructured":"Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R et al. Binding of hepatitis C virus to CD81. Science 1998; 282: 938\u2013941.","journal-title":"Science"},{"key":"BF2403443_CR29","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1084\/jem.20012127","volume":"196","author":"T Yoshida","year":"2002","unstructured":"Yoshida T, Hanada T, Tokuhisa T, Kosai K, Sata M, Kohara M et al. Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation. J Exp Med 2002; 196: 641\u2013653.","journal-title":"J Exp Med"},{"key":"BF2403443_CR30","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1073\/pnas.0303971101","volume":"101","author":"K Machida","year":"2004","unstructured":"Machida K, Cheng KTN, Sung VMH, Shimodaira S, Lindsay KL, Levine AM et al. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci USA 2004; 101: 4262\u20134267.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2403443_CR31","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1182\/blood.V99.6.2259","volume":"99","author":"M Casato","year":"2002","unstructured":"Casato M, Mecucci C, Agnello V, Fiorilli M, Knight GB, Matteucci C et al. Regression of lymphoproliferative disorder after treatment for hepatitis C infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia. Blood 2002; 99: 2259\u20132261.","journal-title":"Blood"},{"key":"BF2403443_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1056\/NEJMoa013376","volume":"347","author":"O Hermine","year":"2002","unstructured":"Hermine O, Lefrere F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002; 347: 89\u201394.","journal-title":"N Engl J Med"},{"key":"BF2403443_CR33","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1056\/NEJM200311203492121","volume":"349","author":"AM Levine","year":"2004","unstructured":"Levine AM, Shimodaira S, Lai MMC . Treatment of HCV-related mantle-cell lymphoma with ribavirin and pegylated interferon alfa. N Engl J Med 2004; 349: 2078\u20132079.","journal-title":"N Engl J Med"},{"key":"BF2403443_CR34","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1046\/j.1365-2141.2003.04751.x","volume":"124","author":"V Pitini","year":"2004","unstructured":"Pitini V, Arrigo C, Righi M, Scaffidi M, Sturniolo G . Systematic screening for HCV infection should be performed in patients with splenic marginal zone lymphoma. Br J Haematol 2004; 124: 252.","journal-title":"Br J Haematol"},{"key":"BF2403443_CR35","first-page":"135","volume-title":"World Health Organization Classification of Tumours. Tumours of Haemopoietic and Lymphoid Tissue. Mature B-cell Neoplasms","author":"ES Jaffe","year":"2001","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW . World Health Organization Classification of Tumours. Tumours of Haemopoietic and Lymphoid Tissue. Mature B-cell Neoplasms. Lyon: IARC Press, 2001, pp 135\u2013138, 157\u2013162."},{"key":"BF2403443_CR36","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1182\/blood.V95.6.1950","volume":"95","author":"F Berger","year":"2000","unstructured":"Berger F, Felman P, Thieblemont C, Pradier T, Baseggio L, Bryon PA et al. Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood 2000; 95: 1950\u20131956.","journal-title":"Blood"},{"key":"BF2403443_CR37","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1182\/blood.V86.12.4691.bloodjournal86124691","volume":"86","author":"EA Macintyre","year":"1995","unstructured":"Macintyre EA, Belanger C, Debert C, Canioni D, Turhan AG, Azagury M et al. Detection of clonal CD34+19+ progenitors in bone marrow of BCL2-IgH-positive follicular lymphoma patients. Blood 1995; 86: 4691\u20134698.","journal-title":"Blood"},{"key":"BF2403443_CR38","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/sj.leu.2401750","volume":"14","author":"E Delabesse","year":"2000","unstructured":"Delabesse E, Burtin ML, Millien C, Madonik A, Arnulf B, Beldjord K et al. Rapid, multifluorescent TCRG Vgamma and Jgamma typing: application to T cell acute lymphoblastic leukemia and to the detection of minor clonal populations. Leukemia 2000; 14: 1143\u20131152.","journal-title":"Leukemia"},{"key":"BF2403443_CR39","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2604::AID-CNCR26>3.0.CO;2-V","volume":"77","author":"C Mazzaro","year":"1996","unstructured":"Mazzaro C, Franzin F, Tulissi P, Pussini E, Crovatto M, Carniello GS et al. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy. Cancer 1996; 77: 2604\u20132613.","journal-title":"Cancer"},{"key":"BF2403443_CR40","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1182\/blood.V97.6.1555","volume":"97","author":"E Zuckerman","year":"2001","unstructured":"Zuckerman E, Zuckerman T, Sahar D, Streichman S, Attias D, Sabo E et al. The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection. Blood 2001; 97: 1555\u20131559.","journal-title":"Blood"},{"key":"BF2403443_CR41","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood.V90.10.3865","volume":"90","author":"M Casato","year":"1997","unstructured":"Casato M, Agnello V, Pucillo LP, Knight GB, Leoni M, Del Vecchio S et al. Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection. Blood 1997; 90: 3865\u20133873.","journal-title":"Blood"},{"key":"BF2403443_CR42","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1182\/blood-2002-05-1537","volume":"102","author":"F Giannelli","year":"2003","unstructured":"Giannelli F, Moscarella S, Giannini C, Caini P, Monti M, Gragnani L et al. Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation. Blood 2003; 102: 1196\u20131201.","journal-title":"Blood"},{"key":"BF2403443_CR43","doi-asserted-by":"publisher","first-page":"602","DOI":"10.7326\/0003-4819-128-7-199804010-00027","volume":"128","author":"M Luppi","year":"1998","unstructured":"Luppi M, Ferrari MG, Torelli G . Hepatitis C virus genotype distribution in B-cell non-Hodgkin lymphoma. Ann Intern Med 1998; 128: 602.","journal-title":"Ann Intern Med"},{"key":"BF2403443_CR44","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/(SICI)1098-2264(199911)26:3<221::AID-GCC6>3.0.CO;2-9","volume":"26","author":"E Callet-Bauchu","year":"1999","unstructured":"Callet-Bauchu E, Gazzo S, Poncet C, Pages J, Morel D, Alliot C et al. Distinct chromosome 3 abnormalities in persistent polyclonal B-cell lymphocytosis. Genes Chromosomes Cancer 1999; 26: 221\u2013228.","journal-title":"Genes Chromosomes Cancer"},{"key":"BF2403443_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1099-1069(200003)18:1<1::AID-HON647>3.0.CO;2-G","volume":"18","author":"J Dierlamm","year":"2000","unstructured":"Dierlamm J, Wlodarska I, Michaux L, Stefanova M, Hinz K, Van Den Berghe H et al. Genetic abnormalities in marginal zone B-cell lymphoma. Hematol Oncol 2000; 18: 1\u201313.","journal-title":"Hematol Oncol"},{"key":"BF2403443_CR46","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1046\/j.0007-1048.2001.03327.x","volume":"116","author":"I Salcedo","year":"2002","unstructured":"Salcedo I, Campos-Caro A, Sampalo A, Reales E, Brieva JA . Persistent polyclonal B lymphocytosis: an expansion of cells showing IgVH gene mutations and phenotypic features of normal lymphocytes from the CD27+ marginal zone B-cell compartment. Br J Haematol 2002; 116: 662\u2013666.","journal-title":"Br J Haematol"},{"key":"BF2403443_CR47","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0145-2126(02)00270-9","volume":"27","author":"K Kanchan","year":"2003","unstructured":"Kanchan K, Loughran Jr TP . Antigen-driven clonal T cell expansion in disorders of hematopoiesis. Leuk Res 2003; 27: 291\u2013292.","journal-title":"Leuk Res"},{"key":"BF2403443_CR48","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1172\/JCI9940","volume":"107","author":"PK Epling-Burnette","year":"2001","unstructured":"Epling-Burnette PK, Liu JH, Catlett-Falcone R, Turkson J, Oshiro M, Kothapalli R et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest 2001; 107: 351\u2013362.","journal-title":"J Clin Invest"},{"key":"BF2403443_CR49","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/0145-2126(92)90047-B","volume":"16","author":"R Metzger","year":"1992","unstructured":"Metzger R, Heckl-Ostreicher B, Nerl C, Schondelmaier S, Kabelitz D . Immunological studies of gamma delta T cells in a case of large granular lymphocyte (LGL) leukemia: leukemic gamma delta+ T cells are resistant to growth stimulation in vitro but respond to interferon-alpha treatment in vivo. Leuk Res 1992; 16: 1087\u20131095.","journal-title":"Leuk Res"},{"key":"BF2403443_CR50","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4049\/jimmunol.130.2.768","volume":"130","author":"BM Vose","year":"1983","unstructured":"Vose BM, Riccardi C, Bonnard GD, Herberman RB . Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. II. Regulatory role of interferon on proliferative and cytotoxic precursors. J Immunol 1983; 130: 768\u2013772.","journal-title":"J Immunol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403443.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403443","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403443.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T03:24:40Z","timestamp":1682738680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,29]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10,1]]}},"alternative-id":["BF2403443"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403443","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,29]]},"assertion":[{"value":"8 December 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}